It's one thing getting your own drug approved. It's another setting up an entire sales side of the business. A one drug company is not efficient nor has the contacts to make regular and quality deals with hospital, specialists, insurers etc.
So they need a pharma deal at the end of the process, anyway.
Ann: Opthea Finalizes Ph 3 Study Designs and Startup Activities, page-19
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.015(3.90%) |
Mkt cap ! $486.2M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.5¢ | 38.5¢ | $264.1K | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 15087 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 20626 | 7 |
View Market Depth
| Last trade - 11.08am 24/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |